Histiocytic sarcoma arising from thyroid gland with BRAF V600E mutation

被引：1
|
作者：
Ge, Rong [1 ]
Chang, Yuqing [2 ]
Gan, Yongli [1 ]
Zhu, Haidong [3 ]
Liu, Chuangfeng [1 ]
机构：
[1] Ningbo Diagnost Pathol Ctr, Dept Diag, Ningbo, Peoples R China
[2] Shibei Hosp, Dept Pathol, Shanghai, Peoples R China
[3] Lihuili Hosp, Dept Radiol, Ningbo Med Ctr, Ningbo, Peoples R China
来源：
PATHOLOGY | 2020年 / 52卷 / 05期
关键词：
D O I：
10.1016/j.pathol.2020.04.012
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
[No abstract available]
引用
收藏
页码：603 / 605
页数：3
相关论文
共 50 条
  • [41] Association between the BRAF V600E mutation and ultrasound features of the thyroid in thyroid papillary carcinoma
    Li, Qian
    Yuan, Jianjun
    Wang, Yan
    Zhai, Yuanpeng
    ONCOLOGY LETTERS, 2017, 14 (02) : 1439 - 1444
  • [42] BRAF V600E Mutations in Infarcted Thyroid Carcinoma
    Kouba, Erik
    Ford, Andrew
    Brown, Charmaine G.
    Yeh, Chen
    Kim, Hyung-Gyoon
    Siegal, Gene P.
    Manne, Upender
    Eltoum, Isam-Eldin
    LABORATORY INVESTIGATION, 2017, 97 : 327A - 327A
  • [43] BRAF V600E mutation is a potential therapeutic target for a small subset of synovial sarcoma
    Watanabe, Sho
    Shimomura, Akihiko
    Kubo, Takashi
    Sekimizu, Masaya
    Seo, Takuji
    Watanabe, Shun-Ichi
    Kawai, Akira
    Yamamoto, Noboru
    Tamura, Kenji
    Kohno, Takashi
    Ichikawa, Hitoshi
    Yoshida, Akihiko
    MODERN PATHOLOGY, 2020, 33 (09) : 1660 - 1668
  • [44] Cerebellar Pleomorphic Xanthoastrocytoma with BRAF V600E Mutation
    Kim, Sang Ho
    Hwang, Kihwan
    Lee, Kyu Sang
    Choe, Gheeyoung
    Kim, Chae-Yong
    WORLD NEUROSURGERY, 2020, 139 : 577 - 581
  • [45] Targeting the BRAF V600E Mutation in Multiple Myeloma
    Andrulis, Mindaugas
    Lehners, Nicola
    Capper, David
    Penzel, Roland
    Heining, Christoph
    Huellein, Jennifer
    Zenz, Thorsten
    von Deimling, Andreas
    Schirmacher, Peter
    Ho, Anthony D.
    Goldschmidt, Hartmut
    Neben, Kai
    Raab, Marc S.
    CANCER DISCOVERY, 2013, 3 (08) : 862 - 869
  • [46] Sequencing Therapies in a Patient With the BRAF V600E Mutation
    Bekaii-Saab, Tanios S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (11)
  • [47] Immunohistochemical analysis of BRAF V600E mutation in ameloblastomas
    Alan Motta do Canto
    Barbara Michaela Reis da Silva Marcelino
    Juliana Lucena Schussel
    Bruna F. Wastner
    Laurindo Moacir Sassi
    Luciana Corrêa
    Ronaldo Rodrigues de Freitas
    Bengt Hasséus
    Göran Kjeller
    Celso Augusto Lemos Junior
    Paulo Henrique Braz-Silva
    Clinical Oral Investigations, 2019, 23 : 779 - 784
  • [48] BRAF V600E in Pediatric Papillary Thyroid Carcinomas
    Paulson, V. A.
    Hollowell, M. L.
    Huang, S. A.
    Barletta, J. A.
    LABORATORY INVESTIGATION, 2014, 94 : 157A - 157A
  • [49] BRAF V600E Inhibition in Anaplastic Thyroid Cancer
    Rosove, Michael H.
    Peddi, Parvin F.
    Glaspy, John A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (07): : 684 - 685
  • [50] Immunohistochemical analysis of BRAF V600E mutation in ameloblastomas
    do Canto, Alan Motta
    Reis da Silva Marcelino, Barbara Michaela
    Schussel, Juliana Lucena
    Wastner, Bruna F.
    Sassi, Laurindo Moacir
    Correa, Luciana
    de Freitas, Ronaldo Rodrigues
    Hasseus, Bengt
    Kjeller, Goran
    Lemos Junior, Celso Augusto
    Braz-Silva, Paulo Henrique
    CLINICAL ORAL INVESTIGATIONS, 2019, 23 (02) : 779 - 784
12345